ArticleScientific reports2026
Evaluation of six eco-analytical tools for the sustainable HPLC analysis of a quinary anti-cold drug mixture.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a novel, eco-friendly RP-HPLC method for determining five key components commonly found in anti-cold pharmaceutical formulations simultaneously: Paracetamol (PAR), an analgesic and antipyretic; pseudoephedrine (PSE), an antihistamine; chlorpheniramine (CHL) and preservatives methylparaben (MET) and propylparaben (PRO). In cold medications, these compounds are often incorporated to treat fever, nasal congestion, and allergic rhinitis symptoms. Chromatographic separation was achieved using an Inert Sustain C18 column (250 × 4.6 mm, 5 μm) under gradient elution mode, with a green mobile phase of ethanol and 0.1% trifluoroacetic acid (pH 2.2), a flow rate of 1.0 mL/min, and ambient temperature (25 °C). Detection was performed using PDA with time-programmed wavelength scanning: 214 nm for PSE, 244 nm for PAR, and 264 nm for CHL, MET, and PRO, ensuring optimal sensitivity and selectivity for each analyte. An analysis of the method went beyond its analytical performance by incorporating six advanced sustainability metrics: MoGAPI, Complex MoGAPI, MoGSA, BAGI, RAPI, VIGI, CACI, and GEARS, which are all designed to provide a multidimensional evaluation of factors such as environmental impact, operational efficiency, and innovation. The STABLE toolkit was applied to all compounds to provide quantitative stability scores and identify vulnerabilities under stress conditions. A low toxicity and biodegradable organic solvent, ethanol, was selected for the organic solvent, while trifluoroacetic acid provided optimal peak resolution under acidic conditions. Analytical validation confirmed excellent linearity (r² > 0.999), precision (%RSD < 2%), and sensitivity, in compliance with ICH guidelines. Using sustainable metrics for routine pharmaceutical analysis is an important step toward eco-friendly chromatographic practices, which is pioneered in this study. Furthermore, it fosters responsible innovation in pharmaceutical quality control by ensuring regulatory compliance and analytical reliability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.